000 01497 a2200421 4500
005 20250515230320.0
264 0 _c20101012
008 201010s 0 0 eng d
022 _a0008-543X
024 7 _a10.1002/cncr.25274
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aBar Ad, Voichita
245 0 0 _aGabapentin for the treatment of pain syndrome related to radiation-induced mucositis in patients with head and neck cancer treated with concurrent chemoradiotherapy.
_h[electronic resource]
260 _bCancer
_cSep 2010
300 _a4206-13 p.
_bdigital
500 _aPublication Type: Evaluation Study; Journal Article
650 0 4 _aAmines
_xadverse effects
650 0 4 _aAnalgesics
_xtherapeutic use
650 0 4 _aCombined Modality Therapy
650 0 4 _aCyclohexanecarboxylic Acids
_xadverse effects
650 0 4 _aFemale
650 0 4 _aGabapentin
650 0 4 _aHead and Neck Neoplasms
_xdrug therapy
650 0 4 _aHumans
650 0 4 _aMale
650 0 4 _aMucositis
_xdrug therapy
650 0 4 _aPain
_xdrug therapy
650 0 4 _aRadiotherapy, Intensity-Modulated
_xadverse effects
650 0 4 _agamma-Aminobutyric Acid
_xadverse effects
700 1 _aWeinstein, Gregory
700 1 _aDutta, Pinaki R
700 1 _aDosoretz, Arie
700 1 _aChalian, Ara
700 1 _aBoth, Stefan
700 1 _aQuon, Harry
773 0 _tCancer
_gvol. 116
_gno. 17
_gp. 4206-13
856 4 0 _uhttps://doi.org/10.1002/cncr.25274
_zAvailable from publisher's website
999 _c19912859
_d19912859